Company*
(Country;
Symbol)

Company

Type/Product Area

Terms/Details (Date)


Affymetrix
Inc.
(AFFX)

Teranode Corp.

Program to support laboratory equipment integration

Teranode is using the Affymetrix Develop- ment Kit in the deal; terms were not disclosed (11/22)

DiscoveRx
Corp.*

B-Bridge International

Partnership to provide Japanese researchers better access to DiscoveRx screening assays

They will collaborate to establish a local presence in Tokyo for DiscoveRx HitHunter products; terms were not disclosed (12/14)

Diversa Corp.
(DVSA)

Givaudan Flavors Corp.

Givaudan licensed the Accentuase-G enzyme for production of a natural flavor ingredient

Under terms of the deal that began in 2002, Diversa gets a license fee and royalties from sales or use of the ingredient; Diversa also will manufacture the enzyme (11/22)

DNA 2.0 Inc.*

MediBIC (Japan)

Collaboration on protein engineering and distribution of gene synthesis in Japan

The consulting company also will be the sole Japanese distributor of DNA 2.0's existing repository of synthesized genes (12/13)

Integrated
Genomics
Inc.*

Chr. Hansen (Denmark)

Chr. Hansen licensed rights to IGI's ERGO database and genomic discovery system

The natural ingredients company will use the system to study probiotics, for developing nutritional food ingredients (12/2)

NuGEN
Technologies
Inc.*

MediBIC Inc.* (Japan)

MediBIC will support the adoption of NuGEN's Ovation family of RNA amplification systems in Asia

Terms of the deal were not disclosed (2/1)

Phenomenome
Discoveries
Inc.*

PrecisionMed Inc.

Collaboration to develop diagnostics for Alzheimer's disease and bipolar disorder

The effort will combine PrecisionMed's clinical samples and information and PDI's discovery and testing platform (2/4)


Notes:

* Private companies are indicated with an asterisk.

Unless otherwise noted, the trading symbols listed for public companies are on the Nasdaq market.

No Comments